ASCO publishes a suite of peer-reviewed journals with content focused on

  • clinical oncology research;
  • issues and insights affecting oncology practice;
  • cancer care, research and care delivery issues unique to countries and settings with limited healthcare resources;
  • biomedical informatics methods and processes applied to cancer-related data, information, and images; and
  • the science and practice of precision oncology.

ASCO’s peer-reviewed journals follow a continuous publication schedule. Below is a select list of the newest content from ASCO’s journals. ASCO will update the list on a near-daily basis, and we encourage you to check this page frequently. Email ASCO’s Media Team to request an embargoed journal article or an interview with a study author.

ASCO occasionally highlights select journal articles in an embargoed press release known as a News Digest or in a Featured Article summary. Sign up to receive communications regarding these articles.

Publishing July 15, 4:00 p.m. ET:

Nab-Paclitaxel: A New Standard of Care in Neoadjuvant Therapy of High-Risk Early Breast Cancer? (JCO: Editorial)
Charles Geyer, et al.
Request this article

Can Administrative Data Improve the Performance of Cancer Clinical Trial Economic Analyses? (JOP: Original Contribution)
Timothy Hanna, et al.
Request this article

Factors Associated With Clinical Deterioration Among Patients Hospitalized on the Wards at a Tertiary Cancer Hospital (JCO: Original Contribution)
Patrick Lyons, et al.
Request this article

Publishing July 12, 4:00 p.m. ET:

Fear of Cancer Recurrence: A Model Examination of Physical Symptoms, Emotional Distress, and Health Behavior Change (JOP: Original Contribution)
Daniel Hall, et al.
Request this article

Publishing July 11, 4:00 p.m. ET:

Ibrutinib Plus Venetoclax in Relapsed/Refractory Chronic Lymphocytic Leukemia: The CLARITY Study (JCO: Rapid Communication)
Peter Hillment, et al.
Request this article

Publishing July 10, 4:00 p.m. ET:

Metastatic Breast Cancer in Kenya: Presentation, Pathologic Characteristics, and Patterns—Findings From a Tertiary Cancer Center (JGO: Original Report)
Shahin Sayed, et al.
Request this article

Publishing July 8, 4:00 p.m. ET:

Neoadjuvant Three-Dimensional Conformal Radiotherapy for Resectable Hepatocellular Carcinoma With Portal Vein Tumor Thrombus: A Randomized, Open-Label, Multicenter Controlled Study (JCO: Original Report)
Shu-Qun Cheng, et al.
Request this article

Patient-Perceived Lack of Choice in Receipt of Radioactive Iodine for Treatment of Differentiated Thyroid Cancer (JCO: Original Report)
Megan Haymart, et al.
Request this article

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study (JCO: Original Report)
Rob Pieters, et al.
Request this article

Late Health Outcomes After Contemporary Lymphome Malin de Burkitt Therapy for Mature B-Cell Non-Hodgkin Lymphoma: A Report From the Childhood Cancer Survivor Study (JCO: Original Report)
Matthew Ehrhardt, et al.
Request this article

Outcome of Infants Younger Than 1 Year With Acute Lymphoblastic Leukemia Treated With the Interfant-06 Protocol: Results From an International Phase III Randomized Study (JOP: Original Contribution)
Rob Pieters, et al.
Request this article

Journey of the Patient With Melanoma: Understanding Resource Use and Bridging the Gap Between Dermatologist, Surgeon, and Oncologist in Different Health Care Systems Cássia (JGO: Special Article)
Rita Pereira da Veiga, et al.
Request this article

Standardization of Education of Patients With Cancer in a Low- and Middle-Income Country: A Quality Improvement Project Using the Cancer and You Booklet (JGO: Original Report)
Jennifer Haley, et al.
Request this article

Living With Neuroendocrine Tumors: Assessment of Quality of Life Through a Mobile Application (JCO CCI: Original Report)
Jared Adams, et al.
Request this article

The embargo date and time of a journal article coincide with its online publication date and time. Journalists may conduct embargoed interviews with study authors up to one week prior to the online publication date. ASCO takes embargo violations seriously and violations typically result in the loss of journal media privileges for a period of one year and may affect broader ASCO media privileges as well. Journalists may request embargoed articles. Please direct further questions regarding the embargo policies for ASCO Journals to the Media Team.